Briacell Therapeutics Corp (BCTX) — Capital Reinvestment Ratio

Latest as of October 2012: 116.84x

Briacell Therapeutics Corp (BCTX) has a Capital Reinvestment Ratio of 116.84x as of October 2012, meaning it reinvests 117% of its operating cash flow ($3.96K) in capital expenditures ($462.21K). Check Briacell Therapeutics Corp (BCTX) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

116.84x

Capex / Operating Cash Flow

Operating Cash Flow

$3.96K

USD

Capital Expenditures

$462.21K

USD

Data as of

Oct 2012

Most recent filing

Annual Capital Reinvestment Ratio for Briacell Therapeutics Corp (None–None)

Year-by-year Capital Reinvestment Ratio for Briacell Therapeutics Corp from None to None. See BCTX FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow